Filtered By:
Cancer: Leukemia
Countries: Egypt Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 149 results found since Jan 2013.
Association of CYP1A1 T3801C (rs4646903) variant with the susceptibility and progression of B-chronic lymphocytic Leukemia (B-CLL) in the Egyptian population
CONCLUSION: Our results showed that the CYP1A1*2A (T3801C, rs4646903) SNP increases the susceptibility to B-CLL incidence and is associated with poor disease progression.PMID:37506988 | DOI:10.1016/j.gene.2023.147673
Source: Gene - July 28, 2023 Category: Genetics & Stem Cells Authors: Menna Al-Adl Afaf El-Said Ahmed El-Sebaie Sherif Refaat Magdy M Youssef Source Type: research
Prognostic Impact of IL17 A Gene Polymorphismson Egyptian Patients with Multiple Myeloma
CONCLUSION: Our research demonstrated that IL-17A polymorphism may not be linked to multiple myeloma susceptibility in our population and did not influence its different clinical and laboratory features. IL-17A polymorphism had no effect on OS in MM patients.PMID:37505775 | DOI:10.31557/APJCP.2023.24.7.2421
Source: Cancer Control - July 28, 2023 Category: Cancer & Oncology Authors: Metwaly Ibrahim Mortada Doaa Shahin Nashwa Abousamra Doaa Abdalla Aladle Shaimaa El-Ashwah F E I Ghobrial M A El-Baiomy Eman A Soliman Nermeen A Niazy Mayada A Ghannam Source Type: research
Association of CYP1A1 T3801C (rs4646903) variant with the susceptibility and progression of B-chronic lymphocytic Leukemia (B-CLL) in the Egyptian population
CONCLUSION: Our results showed that the CYP1A1*2A (T3801C, rs4646903) SNP increases the susceptibility to B-CLL incidence and is associated with poor disease progression.PMID:37506988 | DOI:10.1016/j.gene.2023.147673
Source: Gene - July 28, 2023 Category: Genetics & Stem Cells Authors: Menna Al-Adl Afaf El-Said Ahmed El-Sebaie Sherif Refaat Magdy M Youssef Source Type: research
miR-155 and miR-92 levels in ALL, post-transplant aGVHD, and CMV: possible new treatment options
CONCLUSION: Our study suggests that the plasma signature of microRNA expression may act as a powerful marker for diagnosis and prognosis, providing knowledge outside cytogenetics. Elevation of miR-155 in plasma can be a beneficial therapeutic target for ALL patients, with consideration of higher plasma levels of miR-92 and miR-155 in CMV + and post-HSCT aGVHD patients.PMID:37332027 | DOI:10.1186/s43046-023-00174-3
Source: J Egypt Natl Canc In... - June 18, 2023 Category: Cancer & Oncology Authors: Mahdiyar Iravani Saadi Mohsen Nikandish Zahra Ghahramani Fatemeh Mardani Valandani Maryam Ahmadyan Fakhroddin Hosseini Zahra Rahimian Heeva Jalali Fataneh Tavasolian Ehsan Nabi Abdolyousefi Nadiya Kheradmand Mani Ramzi Source Type: research
Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia
CONCLUSION: ETP-ALL patients tend to have increased mortalities. There was no significant impact of TCR aberrations on the survival rates of the patients.PMID:37303010 | DOI:10.1186/s43046-023-00176-1
Source: J Egypt Natl Canc In... - June 11, 2023 Category: Cancer & Oncology Authors: Mona S El Ashry Enas Radwan Mona S Abdellateif Omar Arafah Naglaa M Hassan Source Type: research
